Photoaffinity Labelling and Solubilization of the Central 5-HT_1A Receptor Binding Site

References

• Green A. R. Neuropharmacology of Serotonin. Oxford University Press, Oxford 1985; 436
   Google Scholar
• Pedigo N. W., Yamamura H. I., Nelson D. L. Discrimination of multiple 3H-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 1981; 36: 220–226
   PubMed Web of Science ®Google Scholar
• Peroutka S. J. Pharmacological differentiation and characterization of 5-HT1A 5-HT1B and 5-HT1C binding sites in rat frontal cortex. J. Neurochem. 1986; 47: 529–540
   PubMed Web of Science ®Google Scholar
• Pazos A., Palacios J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I Serotonin-1 receptors, Brain Res. 1985; 346: 205–230
   PubMed Web of Science ®Google Scholar
• Middlemiss D. N., Fozard J. R. 8-hydroxy-2-(di-n-propylamino)tetralin discriminates between subtypes of 5-HT1 recognition sites, Eur. J. Pharmacol. 1983; 90: 151–153
   Google Scholar
• Marcinkiewicz M., VergÉ D., Gozlan H., Pichat L., Hamon M. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain Res. 1984; 291: 159–163
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Snyder S. H. Multiple serotonin receptors : differential binding of 3H-5-hydroxytryptamine, 3H-lysergic acid diethylamide and 3H-spiroperidol, Mol. Pharmacol. 1979; 16: 687–699
   Web of Science ®Google Scholar
• Leysen J. E., Niemegeers C. J.E., Van Nueten J. M., Laduron P. M. 3H-ketanserin (R 41468), a selective 3H-ligand for serotonin-2 receptor binding sites, Mol. Pharmacol. 1982; 21: 301–314
   Web of Science ®Google Scholar
• Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand : 3H-PAT. Nature 1983; 305: 140–142
   PubMed Web of Science ®Google Scholar
• Middlemiss D. N. 8-hydroxy-2-(di-n-propylamino)tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the 3H-5-HT recognition site, Naunyn-Schmiedeberg's Arch. Pharmacol. 1984; 327: 18–22
   Web of Science ®Google Scholar
• Hamon M., Bourgoin S., Gozlan H., Hall M. D., Goetz C., Artaud F., Horn A. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. Eur. J. Pharmacol. 1984; 100: 263–276
   PubMed Web of Science ®Google Scholar
• Leysen J. E., De Courcelles Dechaffoy D., De Clerck F., Niemegeers C. J.E., Van Nueten J. M. Serotonin-S2 receptor binding sites and functional correlates. Neuropharmacology 1984; 23: 1493–1501
   PubMed Web of Science ®Google Scholar
• Arvidsson L. E., Hacksell U., Nilsson J. L.G., Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikstrom H. 8-hydroxy-2-(di-n-propylamino)tetralin a new centrally acting 5-HT receptor agonist. J. Med. Chem. 1981; 24: 921–923
   PubMed Web of Science ®Google Scholar
• Middlemiss D. N. Functional correlates of the subtypes of the 5-HT1 recognition site. TIPS February, 1986; 52–53
   Web of Science ®Google Scholar
• Dourish C. T., Hutson P. H., Curzon G. Low doses of the putative serotonin agonist, 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology 1985; 86: 197–204
   PubMed Web of Science ®Google Scholar
• Tricklebank M. D., Forler C., Fozard J. R. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur. J. Pharmacol. 1985; 106: 271–282
   Web of Science ®Google Scholar
• Taylor E. W., Duckles S. P., Nelson D. L. Dissociation constants of serotonin agonists in the canine basilar artery correlate with Ki values at the 5-HT1A binding site. J. Pharmacol. Exp. Ther. 1986; 236: 118–125
   PubMed Web of Science ®Google Scholar
• Weiss S., Sebben M., Kemp D. E., Bockaert J. Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons. Eur. J. Pharmacol. 1986; 120: 227–230
   PubMed Web of Science ®Google Scholar
• Schenker A., Maayani S., Weinstein H., Green J. P. Two 5-HT1 receptors linked to adenylate cyclase in guinea pig hippocampus are discriminated by 5-carboxamidotryptamine and spiperone. Eur. J. Pharmacol. 1985; 109: 427–429
   PubMed Web of Science ®Google Scholar
• Devivo M., Maayani S. Characterization of the 5-hydroxy-tryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 1986; 238: 248–253
   PubMed Web of Science ®Google Scholar
• VergÉ D., Daval G., Patey A., Gozlan H., El Mestikawy S., Hamon M. Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur. J. Pharmacol. 1985; 113: 463–464
   PubMed Web of Science ®Google Scholar
• Sprouse J. S., Aghajanian G. K. Serotonergic dorsal raphe neurons: electrophysiological responses in rats to 5-HT1A and 5-HT1B receptor subtype ligands. Soc. Neurosci. 1985; 11–47; 18–19
   Google Scholar
• Stiles G. L., Strasser R. H., Caron M. G., Lefkowitz R. J. Mammalian β-adrenergic receptors. Structural differences in β1 and β2 subtypes revealed by peptide mapping. J. Biol. Chem. 1983; 258: 10689–10694
   PubMed Web of Science ®Google Scholar
• Leeb-Lundberg L. M.F., Dickinson K. E.F., Heald S. L., Wikberg J. E.S., Winn M., Hagen P. O., Debernardis J. F., Arendson D. L., Lefkowitz R. J., Caron M. J. Photoaffinity of mammalian alpha 1-adrenergic receptors. Identification of ligand binding subunit with a high affinity radioiodinated probe. J. Biol. Chem. 1984; 259: 2579–2587
   Google Scholar
• Cheng S. H., Shih J. C. Photoaffinity labelling of serotonin-binding proteins. Life Sci. 1979; 25: 2197–2203
   PubMed Web of Science ®Google Scholar
• Shih J. C., Cheng S. H. Polypeptides involved in postsynaptic serotonin receptors. Adv. Biochem. Psychopharmacol. 1982; 34: 324
   Google Scholar
• Chen S., Shih J. C., Xu Q. P. 4-Fluoro-3-nitrophenylazide. a selective photoaffinity label for type B monoamine oxidase. Biochem. Pharmacol. 1985; 34: 781–788
   Google Scholar
• Gabizon R. T., Yetinson T., Schuldiner S. Photoinactivation and identification of the biogenic amine transporter in chromaffin granules from bovine adrenal medulla. J. Biol. Chem. 1982; 257: 15145–15150
   PubMed Web of Science ®Google Scholar
• Ilien B., Schotte A., Laduron P. M. Solubilized serotonin receptors from rat and dog brain. FEBS Lett. 1982; 138: 311–315
   PubMed Web of Science ®Google Scholar
• Wouters W., Van Dun J., Leysen J. E., Laduron P. M. Solubilization of rat brain serotonin-S2 receptors using CHAPS/ salt. Eur. J. Pharmacol. 1985; 115: 1–9
   PubMed Web of Science ®Google Scholar
• Yagaloff K. E., Hartig P. R. Solubilization and characterization of the serotonin 5-HT1c site from pig choroid plexus. Mol. Pharmacol. 1986; 29: 120–125
   PubMed Web of Science ®Google Scholar
• Rousselle J. C., Gillet G., Fillion G. Solubilization and characterization of 3H-5-HT high affinity binding sites (5-HT1 and 5-HT3). J. Pharmacol. (Paris) 1985; 16: 421–438
   PubMedGoogle Scholar
• Allgren R. L., Kyncl M. M.A., Ciaranello R. D. Pharmacological characterization of solubilized 5-HT1 serotonin binding sites from bovine brain. Brain Res. 1985; 348: 77–85
   PubMed Web of Science ®Google Scholar
• Emerit M. B., Gozlan H., Marquet A., Hamon M. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3′-NAP-amino-PAT. Eur. J. Pharmacol. 1986; 127: 67–81
   PubMed Web of Science ®Google Scholar
• Nelson D. L., Herbet A., Bourgoin S., Glowinski J., Hamon M. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5. 7-dihydroxytryptamine administration in the rat. Mol. Pharmacol. 1978; 14: 983–995
   Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 1970; 277: 680–685
   Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 1265–1275
   Web of Science ®Google Scholar
• Barlow R. B. Biodata Handling with Microcomputers. Elsevier Biosoft, CambridgeUK 1983
   Google Scholar
• Teicher M. H. ALLFIT for Apple II. Biochemical Computing Technology Information Center. Nashville, U.S.A. 1983
   Google Scholar
• Hall M. D., El Mestikawy S., Emerit M. B., Pichat L., Hamon M., Gozlan H. 3H-8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and post-synaptic 5-hydroxytryptamine sites in various regions of the rat brain. J. Neurochem. 1985; 44: 1685–1696
   PubMed Web of Science ®Google Scholar
• Hamon M., Goetz C., Gozlan H. Reciprocal modulations of central 5-HT receptors by GTP and cations. CNS receptors from molecular pharmacology to behaviour, P. Mandel, F. De Feudis. Raven Press, New York 1983; 349–359
   Google Scholar
• Hamon M., Cossery J. M., Spampinato U., Gozlan H. Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain?. TIPS
   Web of Science ®Google Scholar
• Dourish C. T., Hutson P. H., Curzon G. Putative anxiolytics 8-OH-DPAT, buspirone and TVX Q 7821 are agonists at 5-HT1A autoreceptors in the raphe nuclei. TIPS June, 1986; 212–214
   Web of Science ®Google Scholar
• Hall M. D., Gozlan H., Emerit M. B., El Mestikawy S., Pichat L., Hamon M. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physicochemical parameters and modifying agents. Neurochem. Res. 1986; 11: 891–912
   PubMed Web of Science ®Google Scholar
• Gozlan H., Emerit M. B., Hall M. D., Nielsen M., Hamon M. In situ molecular sizes of the various types of 5-HT binding sites in the rat brain. Biochem. Pharmacol. 1986; 35: 1891–1897
   PubMed Web of Science ®Google Scholar